Eton Pharmaceuticals Inc. (NASDAQ: ETON)
$3.63
+0.2900 ( +8.68% ) 204.9K
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
Market Data
Open
$3.63
Previous close
$3.34
Volume
204.9K
Market cap
$92.23M
Day range
$3.16 - $3.75
52 week range
$2.42 - $5.81
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 15 | Jul 15, 2024 |
8-k | 8K-related | 15 | Jun 21, 2024 |
8-k | 8K-related | 14 | Jun 11, 2024 |
8-k | 8K-related | 15 | May 09, 2024 |
10-q | Quarterly Reports | 60 | May 09, 2024 |
8-k | 8K-related | 15 | Apr 30, 2024 |
def | Proxies and info statements | 21 | Apr 26, 2024 |
8-k | 8K-related | 14 | Apr 18, 2024 |
8-k | 8K-related | 15 | Mar 22, 2024 |
10-k/a | Quarterly Reports | 18 | Mar 22, 2024 |